ShadowBuys
Committee overlap: HELP

Sen. Alan Armstrong bought Novartis AG (NVS)

Sen. Alan Armstrong (R-OK) · $15K–$50K · traded Mar 30, 2026

Why this is a committee overlap

Armstrong is a member of the Senate Committee on Health, Education, Labor, and Pensions, which oversees the Healthcare sector. Novartis AG is classified in the Drug Manufacturers - General industry.

An overlap is a fact about the trade, not evidence of wrongdoing. Committee assignments are current ones.

Transaction
Bought
Amount
$15K–$50K
Owner
The member
Traded
Mar 30, 2026
Disclosed
Jul 21, 2026
Days to disclose
113 (after the 45-day deadline)
Asset type
Stock
As filed
Novartis AG Common Stock
Industry
Drug Manufacturers - General · Healthcare

Other trades in this filing

All of Armstrong's trades →

Recent Congress trades in NVS

Company context for NVS

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. NVSCompany announcement·SEC EDGAR

    NVS: 6-K company filing

    Filed 6-K for an event or period dated 2026-09-30. Read the company report for its disclosures.

    Public: Oct 27, 2026, 6:08 AM EDTEvent / period: Sep 30, 2026Original source ↗
  2. NVSRegulatory notice·Federal Register

    Granting of Requests for Early Termination of the Waiting Period Under the Premerger Notification Rules

    A Notice notice explicitly mentions the company. Read the cited text for its role.

    Public: Sep 17, 2026Original source ↗

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.